ONCY

#3427
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.04
1.04
Year Range
0.33
1.51
Daily Change
+10.64%
Monthly Change
+14.29%
6 month change
+4.00%
Year Change
+173.68%
Previous Close
0.9 4
Open
1.0 4
Low
1.0 4
High
1.0 4
Volume
30
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q4, 25Q1, 26 TTM

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

News